Medidata

AI is reshaping clinical trial execution. How can the industry maximize its full potential?

Caitlyn Rice’s 2026 COG: Small and Mid BioPharma Summit session "AI Revolution: Ready to Reimagine Study Build” explores the impact of next-generation technology on research design, and how AI agents can reduce delays, break down silos, and improve compliance for faster, more effective outcomes.

Stop by Booth #26 to meet the team and continue the conversation!

#ComeToCOG #AIforImpact #Medidata

While nearly 73% of early AI adopters see tangible trial acceleration, too many teams remain stuck in pilot purgatory.

At @HLTHEVENT USA, Lisa Moneymaker is joining @hcittoday's @Colin_Hung for a fireside chat on turning AI promise into measurable clinical execution. They’ll discuss how organizations can deploy clinically fluent, human-led AI to remove structural bottlenecks, eliminate operational friction, and compress timelines.

📍 "Pharma Insights: How AI Is Revolutionizing Clinical Trials"
🗓️ November 16 at 11:10–11:30 AM PT

From Virtual Twins to unified data platforms, we can now simulate study performance, stress-test protocols, and identify enrollment hurdles before a single patient ever enrolls. We can't wait to show you how it all works!

If you're attending, be a part of the conversation: mdso.io/m3t

#HLTHUSA #AIforImpact #Medidata

What if you could boost patient retention while building safer, more efficient studies?

In @FiercePharma’s live Virtual Workshop, @AusTXTucker will join Troy Internal Medicine’s Ashley Hopkins, @PrometrikaCRO’s Chelsey Ryan, and our Patient Insights Board member @bjork5 to examine how unifying automated payments with travel concierge services creates a simpler, smarter, and more supportive experience across the clinical trial lifecycle.

Register here: mdso.io/r7e

#Medidata

AI is supposed to fix silos in clinical trials. But when organizations introduce isolated pilots, multiple vendors, and fragmented point solutions, silos don't just multiply: they prevent scaling across studies.

That’s why leaders like @worldwidetrials choose Medidata Plus instead.

Learn more about their journey alongside insights from @EverestGroup on how to overcome AI scaling barriers: mdso.io/yab

#AIforImpact #Medidata

BREAKING NEWS: Medidata’s Synthetic Control Arm® (SCA®) has been named the “Real-World Evidence (RWE) Solution of the Year” in the 6th annual @BioTech_Awards! 🏆

Enrolling patients into a placebo or standard-of-care arm is often difficult, particularly in rare disease studies where treatment options are limited. Our AI-powered SCA® leverages validated, historical data from over 42,000 clinical trials and 13 million patients to bridge the gap, accelerating research and bringing therapies to market faster.

Learn more: mdso.io/o19

#BiotechBreakthrough #AIforImpact #Medidata